Imagine being able to look inside a single cancer cell and see how it communicates with its neighbors. Scientists are celebrating a new technique that lets them study the fatty contents of cancer cells, one by one.
A study led by the University of Surrey has sampled single live cancer cells and measured the fatty lipid compounds inside them. Working with partners at GSK and UCL, and developing new equipment with Yokogawa, the team saw how those cells transformed in response to changes in their environment.
The work appears in Analytical Chemistry.
Dr. Johanna Von Gerichten, from Surrey’s School of Chemistry and Chemical Engineering, noted, “The trouble with cancer cells is that no two are alike. That makes it harder to design good treatment, because some cells will always resist treatment more than others. Yet it has always proven tricky to study live cells after they have been removed from their natural environment, in enough detail to truly understand their makeup. That is why it is so exciting to be able to sample live cells under a microscope and study their fatty contents one by one.”
Individual pancreatic cancer cells were lifted from a glass culture dish using Yokogawa’s Single Cellome System SS2000. This extracts single live cells using tiny tubes 10 µm across—about half the diameter of the thinnest human hair.
By staining the cells with fluorescent dye, the researchers could monitor lipid droplets (stores of fatty molecules inside cells, thought to play an important role in cancer) throughout the experiment.
Then, working with partners at Sciex, researchers developed a new method using a mass spectrometer to fragment the lipids in the cells. This told them about their composition.
The researchers demonstrated that different cells had very different lipid profiles. They also saw how lipids in the cells changed in response to what was going on around them.
“We are really excited to work with scientists from all over the UK to apply this to other types of cells, to better understand infection, immunity and other phenomena as part of our new national facility for single and sub-cellular “omics,” SEISMIC,” Professor Melanie Bailey said.
“We are also part of an International Atomic Energy Agency program, which is exploring the effects of irradiation on cells. We will be working with researchers from all over the world to understand why some cancer cells resist radiation treatment.”
Dr. Carla Newman, Associate Director, Cellular Imaging and Dynamics at GSK, observed, “Our new method paves the way for studying cancer cells in detail we’ve never seen before. One day, we might be able to see how individual cancer cells communicate with their neighbors. That could unlock new, more targeted treatments. It’s great to see universities and industry come together to produce such ground-breaking research.”
More information: Untargeted single-cell lipidomics using liquid chromatography and data-dependent acquisition after live cell selection, Analytical Chemistry (2024). DOI: 10.1021/acs.analchem.3c05677
Journal information: Analytical Chemistry
Provided by University of Surrey
News
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]















